Mindray Stock - analyst consensus and technicals in focus
18.06.2026 - 19:58:32 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 19:57 CET. Details in the imprint.
Mindray (CNE100003G62) is a heavyweight in Chinese medical technology, yet on Thursday there is no fresh market-moving company news from its investor relations or major wire services. Instead, attention turns to how analysts value the stock and where the shares stand on the chart.
Background and data on Mindray stock
Key figures, filings and archived reports on Mindray stock are summarized in the ad hoc news topic section and on the company’s own investor-relations pages.
What analysts currently say
Mindray publishes detailed financial and operating data on a quarterly and annual basis, which provides the basis for analyst models and consensus estimates. The company’s latest full-year and interim figures are available in its English-language annual and interim reports on the investor-relations site. The Mindray IR reports section outlines historical revenue, profit and cash-flow trends.
Sell-side coverage on Mindray is concentrated among Asian and global investment banks that track Chinese healthcare and medical-technology stocks. These institutions typically focus on procedure volumes, equipment replacement cycles and public-hospital spending as key drivers when they update their earnings and valuation models for the company.
Chart picture and key levels
On Thursday, the market’s technical focus for Mindray is less about a single day’s move and more about where the shares trade relative to medium and long-term moving averages. For many chart-oriented market participants, the 50-day and 200-day lines provide a reference for prevailing trend strength.
Traders in Chinese healthcare stocks also watch how individual names such as Mindray behave compared with broader healthcare indices and large domestic peers. Technical investors often look for confirmations, for example when the stock price crosses above or below major moving averages with increased trading volume.
How the company makes money
Mindray’s business centers on medical devices and solutions for hospitals and clinics, including patient monitoring systems, in-vitro diagnostic equipment and imaging products. The group generates revenue globally by supplying hardware, related software and consumables for routine clinical use.
Where the stock trades today
The shares of Mindray (CNE100003G62) trade on the Shenzhen Stock Exchange in CNY; the most recent live-verified price and timestamp are available on the home-market quote pages and major financial data platforms tracking Chinese A-shares.
Key facts on Mindray stock
- Company: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- ISIN: CNE100003G62
- WKN: not live-verified
- Ticker: not live-verified
- Venue: SZSE (Shenzhen Stock Exchange)
- Price (as of 06/18/2026, 19:57 CET): not live-verified
- Market cap: not live-verified
- Sector / Industry: Health Care / Medical Equipment
- Index membership: not live-verified
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
